Preventive chemotherapy effectiveness in children and adolescents, contacting TB patients with DR TB strains

O. V. Kasimtseva, E. S. Ovsyankina, I. A. Vassilyeva (Moscow, Russian Federation)

Source: Annual Congress 2006 - Epidemiology and control of tuberculosis
Session: Epidemiology and control of tuberculosis
Session type: Oral Presentation
Number: 3099
Disease area: Paediatric lung diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. V. Kasimtseva, E. S. Ovsyankina, I. A. Vassilyeva (Moscow, Russian Federation). Preventive chemotherapy effectiveness in children and adolescents, contacting TB patients with DR TB strains. Eur Respir J 2006; 28: Suppl. 50, 3099

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effectiveness of treatment for MDR TB in children and adolescents
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007


TB-incidence and role of preventive chemotherapy in children and adolescents from bacillary DR TB-pestholes
Source: Eur Respir J 2007; 30: Suppl. 51, 413s
Year: 2007

Multidrug-resistance tuberculosis and HIV-infected patients, the effectiveness of the treatment in Ukraine
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010


New approaches to MDR/XDR TB chemotherapy in children and adolescents
Source: International Congress 2019 – Tuberculosis: treatment and management
Year: 2019

Challenges in TB treatment in children
Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults
Year: 2014

The effectiveness of MDR TB treatment in children and adolescents depending on its duration
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012

The effectiveness of the treatment of patients with TB in the condition adapted DOTS-strategy in Ukraine
Source: Annual Congress 2008 - Outcomes of tuberculosis treatment
Year: 2008


Comparison of compliance of two therapeutic regimens in treatment of latent tuberculosis infection in Belgrade children
Source: Eur Respir J 2004; 24: Suppl. 48, 648s
Year: 2004

Challenges in TB treatment in adults
Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults
Year: 2014




Prevention of TB in areas of high incidence
Source: Eur Respir Mon 2012; 58: 84-94
Year: 2012


Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study
Source: Eur Respir J 2001; 18: 369-375
Year: 2001



Use of shortened chemotherapy regimens in treatment of adolescents with MDR/XDR TB
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018

The clinical features and treatment of cases with MDR TB of adolescents
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007


Identification and clinical management of LTBI in children versus adults
Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults
Year: 2014




HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015

The comparative analysis of treatment effectiveness in children and adolescents with MDR TB with anti-TB drugs of the first and second lines
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012

Using results of drug sensitivity of infection source in initial chemotherapy choice in TB children and teenagers
Source: Eur Respir J 2006; 28: Suppl. 50, 12s
Year: 2006

Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015